Drug Research
Drug Discovery & Development

Covance establishes three new offices in Ukraine, Slovakia and Israel

PBR Staff Writer Published 06 February 2009

Covance, a provider of clinical development services, has opened three new clinical development offices in Kiev, Ukraine; Bratislava, Slovakia; and Tel Aviv, Israel to further enhance the company's global presence.

The new offices located in Kiev and Bratislava will support staff in Ukraine and Slovakia, including Covance's regional network of field-based clinical research associates throughout central and eastern Europe and the former Soviet Union.

Covance said that it has been providing clinical trial support in southeastern Europe (Greece and Turkey) and the Middle East (Israel and Egypt), with Israel being a strategic location since 1995. The new Tel Aviv office serves to center operations and support staff across both regions.

Covance believes that the new offices and expanded staff will help the company expedite the execution of clinical studies and build strategic relationships with investigators and sites in countries well known for their potential to contribute to global clinical trial conduct.

Robert Davie, vice president and general manager of clinical development services for Europe at Covance, said: The establishment of this series of three new offices indicates our commitment to serve the needs of our clients for high-quality and timely clinical development on a global basis, leveraging the patient and investigator potential of emerging markets.

We will continue moving forward with our strategy to expand into geographies that align our therapeutic focus with investigators that consistently demonstrate high-quality results, regulatory compliance and enrollment performance to meet the current and future clinical research needs of our clients.